ZYKADIA – (ceretinib)

Zykadia is an anticancer medicine used on its own for the treatment in adults of a type of lung cancer called non-small cell lung cancer (NSCLC), when the disease is advanced. It is only used if the NSCLC is “ALK-positive”, which means that the cancer cells have certain defects that affect the gene responsible for a protein called ALK (anaplastic lymphoma kinase).